The U.S. Food and Drug Administration granted premarket notification clearance for two catheters originally developed by Riyaz Bashir, MD, FACC, Professor of Medicine at the Lewis Katz School of Medicine at Temple University and Director of Vascular and Endovascular Medicine at Temple University Hospital; and Nicholas Green, Director of Research and Development at Thrombolex, Inc. The announcement received coverage from Endovascular Today, Scienmag and Bioengineer.org.
Weather Alert: A major winter storm is likely to impact the Philadelphia region this weekend into Monday. Temple Health remains open, though some appointments or services may be adjusted. Patients will be contacted directly if their visit is affected. Please check TempleHealth.org for updates and monitor myTempleHealth for changes to scheduled appointments.
800-TEMPLE-MED
Schedule Appointment
SEARCH TEMPLE HEALTH